Salud y medicina de la mujer

Front Cover
Elsevier España, 2000 - Medical - 598 pages
Women's Medicine and Health
 

What people are saying - Write a review

User Review - Flag as inappropriate

talomerasa longevidad celular

Contents

Problemas específicos de la hipertensión arterial de la mujer
311
Asistencia a la hipertensa
317
Hipercolesterolemia
327
Angina e infarto de miocardio
337
Cardiopatía isquémica
349
Problemas endocrinológicos 32 Enfermedades de la glándula tiroides
355
Diabetes
369
Obesidad
379

Anticonceptivos orales
97
Cuidados preventivos en la mujer gestante
113
Sexualidad y salud
123
Menopausia y posmenopausia
133
Problemas del aparato reproductor 13 Dismenorrea
149
Síndrome premenstrual
159
Esterilidad e infertilidad
171
Sangrado vaginal anómalo
195
Dolor pélvico crónico
207
Enfermedades benignas de la mama
217
Cáncer de mama
225
Cáncer de ovario
239
Lesiones premalignas y cáncer de cérvix
247
Cáncer de endometrio
255
Enfermedades infecciosas 23 Enfermedades de transmisión sexual
263
El SIDA qué hay de diferente?
277
Anemias
287
Riesgo cardiovascular diferencial
303
Estados hiperandrogénicos
397
Problemas musculosqueléticos 36 Osteoporosis posmenopáusica
415
Patología osteoarticular más frecuente
423
origen o consecuencia del efecto dominó
439
Trastorno disfórico premenstrual
453
Migraña
461
Enfermedad de Alzheimer
475
Ictus
493
Aparato respiratorio 43 Enfermedades respiratorias
503
Aparato digestivo 44 Enfermedades gastrointestinales
521
Aparato genitourinario 45 Incontinencia urinaria
537
Piel
543
Enfermedades dermatológicas
547
pautas de actuación médica
565
Violencia
571
Indice de materias
583
Copyright

Common terms and phrases

Popular passages

Page 343 - Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
Page 343 - Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
Page 343 - The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
Page 15 - Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
Page 343 - Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Page 418 - Cummings SR, Eckert S, Krueger KA et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial.
Page 312 - Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC VI).
Page 418 - Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
Page 15 - Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group.

Bibliographic information